NCT07327944Not yet recruiting
Relapse Management Group Psychoeducation Program
Effects of Relapse Management Group Psychoeducation Program Applied to Schizophrenia Patients on Relapse Management and Functional Recovery
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
This study was planned to be conducted between February and March 2026, with a total of 60 patients diagnosed with schizophrenia who met the inclusion criteria and were followed at the community mental health center in the Psychiatry Building of Ankara Etlik City Hospital. 30 patients were in the experimental group and 30 were in the control group.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 26 Dec 2025
- Start date
- 1 Feb 2026
- Primary completion date
- 28 Feb 2026
- Lead sponsor
- Ankara Etlik City Hospital
- Diseases
- Schizophrenia
- NCT number
- NCT07327944
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Feb 2026 to the primary completion date, 28 Feb 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Age 18 and over
- Able to speak and understand Turkish
- Written consent obtained
- Being a patient diagnosed with schizophrenia who is being monitored at the relevant institution during the study period
- Being in remission Exclusion Criteria
- Those who have previously received or are currently receiving psychoeducation on relapse management
- Those who do not attend community mental health center follow-ups regularly
- Those with mental retardation that may prevent participation in psychoeducation
- Those in the relapse phase of the disease
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.